DMHCA ibrate is a potent FLT3/AXL inhibitor

is a potent FLT3/AXL inhibitor

6(29):28312-26

Formula: C12H9Cl2NO4

a selective ligand at I1-R

The mitogen-activated protein kinase (MAPK)/ERK pathway is often upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation

DMHCA ibrate is a potent FLT3/AXL inhibitorDMHCA, a potent and selective LXR agonist, specifically activates the cholesterol efflux arm of the LXR pathway without stimulating triglyceride synthesis. DMHCA has anti inflammatory effects and can be used for the research of cholesterol homeostasis diabetes. Product information CAS Number: 79066 03 8 Molecular Weight: 401. 63 Formula: C26H43NO2 Chemical Name: (4R) 4 [(1R,3aS,3bS,7S,9aR,9bS,11aR) 1,3a,3b,9b tetrahydrogenio 7 hydroxy 9a,11a dimethyl